Olainfarm
 company logo | |
| Type | Joint stock company |
|---|---|
| Traded as | OMX: OLF1R |
| Industry | Pharmaceuticals |
| Predecessor(s) | Olaine Chemical-Pharmaceutical Plant |
| Founded | 10 June 1991[1] |
| Headquarters | Olaine, Latvia |
| Area served | Worldwide |
| Key people | Valērijs Maligins (CEO) |
| Revenue | € 75,2 million (2012) |
| Net income |
 € 13,8 million (2012) |
| Owner(s) | Olmafarm (42.56%) Valērijs Maligins (27.83%) |
| Website | olainfarm.lv |
AS Olainfarm (OMX: OLF1R) is a Latvian company listed on the Riga OMX exchange with production of pharmaceutical drugs,chemical ingredients and active pharmaceutical ingredients. Products of JSC Olainfarm are exported to more than 35 countries, including the Baltic States, Russia, other CIS countries, Scandinavian, Western European and Asian countries, as well as North America and Australia.
The Company was founded in 1972 as state enterprise “Olaines ķīmiski – farmaceitiskā rūpnīca” (Olaine Chemical-Pharmaceutical Plant). The main goal of founding the Company was to ensure pharmaceutical substances and semiproducts to several finished drug form manufacturing plants in the Soviet Union. As a result of privatization in 1997, the Company was reorganized into a joint stock company and its shares were listed on stock exchange. Starting from 1 December 2006, shares of JSC Olainfarm are listed in the Main List of stock exchange NASDAQ OMX Riga.
In 2012, Olainfarm had a turnover of € 75,2 million with a profit of € 13,8 million.
References
- ↑ "Joint Stock Company Olaine Annual Report 2009". nasdacomxbaltic.com. 2010-04-01. p. 5. Retrieved 2010-11-03.
| |||||
